Checking an Authorized Drug Supply-Chain Trading Partner

DSCSA requires pharmacies to work with authorized trading partners. FDA advises pharmacies to check a wholesale distributor’s valid state license and its submission to FDA’s annual reporting database. Verify the exact facility and state, retain procurement records, and escalate a supplier whose identity or authorization cannot be confirmed.

Why the supplier matters

A legitimate-looking bottle can enter a pharmacy through an unsafe route. DSCSA requires trading partners in the prescription drug supply chain to meet applicable licensing, registration, and authorization requirements. FDA warns that unlicensed or unauthorized partners can expose patients to counterfeit, stolen, diverted, or otherwise illegitimate products. Checking the supplier is a procurement safety control, not merely vendor onboarding paperwork.

Check the facility license

FDA advises checking the state licensure website for the wholesale distributor or third-party logistics provider and confirming a valid license in the state where it conducts business. A distributor may operate multiple facilities and hold multiple licenses, so verify the actual location that handles or sells the product. A company’s name alone may not identify every facility or license status.

Check FDA annual reporting

Wholesale drug distributors and 3PLs must submit licensure and other information to FDA annually to be authorized trading partners under DSCSA. FDA provides a public annual reporting database. The pharmacy should use that database along with state records. One check does not replace the other: state license status and FDA reporting each inform the authorization assessment.

When to recheck

Verify a new supplier before accepting product and repeat checks as required by policy, when licenses renew, and when there is a change in facility, ownership, name, or contact information. A supplier’s status can change. Maintain a record of the date, data source, facility, and result. If a transaction appears to come from a different location than the approved account, stop and confirm before receiving.

What technicians can notice

Receiving staff may be the first to spot a mismatch: an unfamiliar shipper, altered invoice, unexpected delivery location, damaged seals, or products that do not match the purchase order. Do not use a familiar logo as proof of authorization. Compare the sender and facility with the approved supplier list, and report discrepancies to the pharmacist or purchasing/compliance lead.

What to do if the check fails

Do not accept or place the product into active inventory until the responsible person resolves the concern. Keep the shipment segregated, preserve packaging and paperwork, and contact the supplier using a verified contact channel. If the source cannot be confirmed or other signs suggest illegitimacy, follow DSCSA suspect-product procedures. Do not “solve” a mismatch by editing the supplier record or invoice.

3PLs and wholesale distributors differ

A wholesale distributor takes ownership or otherwise engages in wholesale distribution; a third-party logistics provider provides logistics services such as warehousing or fulfillment without taking ownership in the same way. The exact legal category depends on activities, not simply a vendor’s marketing description. Both may need authorization under DSCSA. FDA’s guidance and database help identify the correct status; a pharmacy compliance lead should resolve edge cases.

Example: new source after a backorder

A regular wholesaler is out of stock, and a salesperson offers the same medication from a different facility. Before purchasing, the pharmacy verifies the source facility’s state license and FDA annual reporting status and confirms the transaction uses an approved account. If staff cannot validate the source, they do not accept the shipment as ordinary stock. The pharmacist or procurement lead evaluates next steps.

PTCE takeaway

Verify trading partners using state licensure and FDA’s annual reporting database. Confirm the exact facility, document checks, and hold product when supplier identity or authorization is uncertain.

Operational checks that prevent mix-ups

A useful verification log records the vendor’s legal name, specific facility address, state license number and expiration, FDA reporting database result, date checked, and staff member who performed the check. Compare those details with the purchase order, invoice, and ship-from address. If the vendor operates under a trade name or uses a 3PL, document the relationship and determine which entity is acting as the wholesaler and which is providing logistics. FDA databases and state portals can have update delays; an apparent mismatch should be investigated with the vendor and regulator records, not dismissed. Keep the product segregated until resolved. This process is especially important when a pharmacy is offered a one-time deal, a new source during a shortage, or a shipment from an unfamiliar location.

Scope and handoff details

A supplier verification process should distinguish a routine purchase from a transfer between pharmacies or a purchase from a returns processor. DSCSA recognizes different trading-partner roles, and a company can perform more than one role. Ask the compliance lead to classify unusual business arrangements before accepting ownership of product. A third-party logistics provider may coordinate warehousing but is not automatically the seller or owner; the wholesale distributor that sold the drug remains a separate entity to verify. Keep the source trace data with the purchase record so staff can connect authorization checks to the actual product transaction. This makes the verification useful during an inspection or recall, rather than a stale onboarding checkbox disconnected from the shipment.

A useful handoff

When the pharmacy accepts product, preserve the invoice, delivery record, tracing data, and supplier identity together. If one item is absent, request it promptly and document the follow-up. A verified vendor account does not prove that every later transaction or ship-from site is valid; continue checking for unexpected changes at receiving.

Points to carry into practice

• Check the current FDA or DEA source and the pharmacy SOP for the exact requirement.
• Hold and escalate an unresolved discrepancy instead of guessing or bypassing a control.